Needles vs. cancer: acupuncture may supercharge immunotherapy
NCT ID NCT06461338
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding acupuncture to standard immunotherapy and chemotherapy helps people with advanced non-small cell lung cancer. Sixty participants will receive either real or sham acupuncture alongside their first four treatment cycles. The goal is to see if acupuncture can improve how well the cancer responds and extend survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guangdong Provincial Hospital of Chinese Medicine
Guangzhou, Guangdong, 510120, China
-
Jiangsu Provincial Hospital of Chinese Medicine
Nanjing, Jiangsu, 210000, China
-
The First Affiliated Hospital of Guangzhou University of Chinese Medicine.
Guangzhou, Guangdong, 510000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Can a targeted pill keep lung cancer from returning?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?